ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AVTI Avitar Inc (CE)

0.000001
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Avitar Inc (CE) USOTC:AVTI OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Avitar to Present at 4th Annual PIPEs Conference 2006 on Nov. 7-8, in New York City

01/11/2006 4:03pm

PR Newswire (US)


Avitar (CE) (USOTC:AVTI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Avitar (CE) Charts.
CANTON, Mass., Nov. 1 /PRNewswire-FirstCall/ -- Avitar (OTC:AVTI) (BULLETIN BOARD: AVTI) will present at the 4th Annual PIPEs Conference 2006 being held in New York City at The Waldorf-Astoria Hotel on November 7 and 8, 2006. Avitar will present on Tuesday, November 7th at both 9:30 AM and 10:00 AM and at 9:00 AM EST, on Wednesday, November 8th. Pete Phildius, Chief Executive Officer of Avitar, and Jay Leatherman, Chief Financial Officer, will discuss both the corporate and financial highlights of the Company. Conference officials estimate this year's audience to be in excess of 1,000 people, consisting primarily of investors, investment bankers, attorneys, company executives and industry analysts active in the small cap equity market. The conference includes CLE-accredited workshops, roundtables, and presentations from leading industry professionals. Information about the event can be found at http://www.thepipesconference.com/. About Avitar, Inc. Avitar, Inc. develops, manufactures and markets innovative and proprietary products. Its field includes the oral fluid diagnostic market, the disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Avitar manufactures ORALscreen(R) the world's first non-invasive, rapid, on-site, fluid-based oral screening test for drugs-of-abuse, as well as HYDRASORB(R), an absorbent topical dressing for moderate to heavy exudating wounds. Avitar is also developing diagnostic strategies for disease and clinical testing in the estimated $25 billion in-vitro diagnostics market. Conditions targeted include influenza, diabetes, and pregnancy. For more information, visit Avitar's Web site at http://www.avitarinc.com/. Forward Looking Statements This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements. Contact: Jay C. Leatherman Avitar Inc. 781-821-2440 http://www.avitarinc.com/ The Investor Relations Group Investors: Erika Moran/Tom Caden, 212-825-3210 Media: Bill Douglass, 212-825-3210 DATASOURCE: Avitar, Inc. CONTACT: Jay C. Leatherman of Avitar Inc., +1-781-821-2440, ; or Investors: Erika Moran, , or Tom Caden, , +1-212-825-3210, or Media: Bill Douglass, +1-212-825-3210, , all of The Investor Relations Group Web site: http://www.avitarinc.com/ http://www.thepipesconference.com/

Copyright

1 Year Avitar (CE) Chart

1 Year Avitar (CE) Chart

1 Month Avitar (CE) Chart

1 Month Avitar (CE) Chart

Your Recent History

Delayed Upgrade Clock